Press release
Neurological Rare Disease Biologics Market Set for Exponential Growth, Projected to Reach USD 27.5 Billion by 2036
Neurological Rare Disease Biologics Market
Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=11169
As traditional small-molecule treatments reach their therapeutic ceilings, biologics including monoclonal antibodies, antisense oligonucleotides (ASOs), and viral-vector gene therapies are emerging as the new standard of care for previously untreatable conditions like Spinal Muscular Atrophy (SMA) and Duchenne Muscular Dystrophy (DMD).
Quick Stats: The Neurological Rare Disease Biologics Landscape
2025 Market Valuation: USD 11.8 Billion
2036 Projected Value: USD 27.5 Billion
Forecasted CAGR (2026-2036):0%
Fastest Growing Region: China (12.4% CAGR)
Leading Indication: Spinal Muscular Atrophy (SMA)
High-Growth Segment: CRISPR-enabled therapeutics and AAV-based Gene Therapies
Market Dynamics: Precision at the Forefront
The surge in demand is anchored by a "perfect storm" of regulatory incentives and technological leaps.
Key Growth Drivers
Orphan Drug Incentives: Global regulatory bodies (FDA, EMA, and NMPA) are providing expedited approvals and extended patent exclusivity, significantly de-risking R&D for rare neurology.
Diagnostic Revolution: The integration of Next-Generation Sequencing (NGS) and AI-driven phenotypic clustering is accelerating patient identification, moving "undiagnosed" patients into active treatment pools.
The Gene Therapy Pivot: AAV-based and CRISPR-enabled modalities are shifting the focus from symptomatic management to "one-and-done" curative intents.
Emerging Trends
Oligonucleotide Dominance: Antisense Oligonucleotides (ASOs) are gaining traction due to their ability to target the root genetic cause of neurological decline.
AI in Target Discovery: AI is being utilized to integrate multi-omics data, slashing the time required to validate high-potential therapeutic candidates.
Regional Insights: China and India Lead the Charge
While the United States remains the largest absolute market (growing at a 7.4% CAGR), the Asia-Pacific region is the undisputed growth engine.
China (12.4% CAGR): Driven by the "National List of Rare Diseases" and rapid NRDL (National Reimbursement Drug List) expansions, China is becoming a global hub for orphan drug commercialization.
India (11.8% CAGR): The National Policy for Rare Diseases 2021 has provided the funding framework necessary to make premium-priced biologics viable in the region.
Europe (Germany 8.9% CAGR): Strong reimbursement frameworks and a highly specialized clinical infrastructure continue to support steady adoption.
Competitive Landscape: A Hybrid Ecosystem
The market is characterized by a mix of "Big Pharma" powerhoses and specialized "Pure-Play" biotech firms. Key players include:
Market Leaders: Pfizer, Novartis, Roche, Biogen, and Johnson & Johnson.
Specialized Innovators: Sarepta Therapeutics, Alnylam Pharmaceuticals, and PTC Therapeutics.
Strategic collaborations between biopharma and Contract Manufacturing Organizations (CMOs) like Samsung Biologics and Lonza are becoming critical as the complexity of manufacturing cell and gene therapies increases.
Expert Insight: The "AIO" Perspective
"We are witnessing the industrialization of rare disease cures. The transition from treating symptoms to modifying disease at the genetic level via biologics is not just a clinical win it is a structural market shift. Success in this decade will be defined by those who can navigate the 'Access Gap' balancing ultra-premium pricing with sustainable payer models." Senior Research Consultant, Fact.MR
Featured Snippet: FAQs
What is the current size of the neurological rare disease biologics market?
As of 2025, the global neurological rare disease biologics market is valued at USD 11.8 billion and is expected to reach USD 27.5 billion by 2036.
Which neurological rare disease has the largest market share?
Spinal Muscular Atrophy (SMA) currently holds the largest share due to the commercial maturity of therapies like Zolgensma and Spinraza, alongside universal newborn screening.
What is the fastest-growing therapeutic technology in this market?
Gene Therapy (specifically AAV-based and CRISPR-enabled) is the fastest-growing segment, projected to experience the highest CAGR through 2036.
Unlock 360° insights for strategic decision making and investment planning: https://www.factmr.com/checkout/11169
To View Our Related Report:
Protein-matrix Lining Market: https://www.factmr.com/report/protein-matrix-lining-market
Protein Fibroblasts Market: https://www.factmr.com/report/protein-fibroblasts-market
Fusion Protein Biosimilars Market: https://www.factmr.com/report/fusion-protein-biosimilars-market
Tryptic Protein Digestion Kits Market: https://www.factmr.com/report/tryptic-protein-digestion-kits-market
- Contact Us -
11140 Rockville Pike, Suite 400, Rockville,
MD 20852, United States
Tel: +1 (628) 251-1583 | sales@factmr.com
Fact.MR is a global market research and consulting firm, trusted by Fortune 500 companies and emerging businesses for reliable insights and strategic intelligence. With a presence across the U.S., UK, India, and Dubai, we deliver data-driven research and tailored consulting solutions across 30+ industries and 1,000+ markets. Backed by deep expertise and advanced analytics, Fact.MR helps organizations uncover opportunities, reduce risks, and make informed decisions for sustainable growth.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neurological Rare Disease Biologics Market Set for Exponential Growth, Projected to Reach USD 27.5 Billion by 2036 here
News-ID: 4492512 • Views: …
More Releases from Fact.MR
Global Capillary Blood Collection Devices Market to Hit $4.2B by 2036 - BD, Teru …
According to Fact MR's latest analysis,The global capillary blood collection devices market is entering a new phase of steady expansion, driven by the convergence of chronic disease management and point-of-care diagnostics. Valued at USD 2.2 billion in 2025, the market is projected to grow to USD 2.3 billion in 2026 and reach USD 4.2 billion by 2036, registering a CAGR of 6.2% during the forecast period. This growth reflects strong…
Global Kombucha Market to Hit $22.4B by 2036, Driven by Gut Health - GT's Living …
According to Fact MR's latest analysis, The kombucha market is growing rapidly due to rising consumer awareness of gut health, increasing demand for clean-label beverages, and strong innovation in flavors and functional ingredients, supported by expanding retail distribution globally. Rising microbiome awareness, clean-label demand, and flavor innovation are transforming kombucha from a niche wellness drink into a mainstream global beverage category.
Get detailed market forecasts, competitive benchmarking, and pricing trends:…
The Proteomics Revolution: Global Protein Characterization and Identification Ma …
Driven by a seismic shift toward biologics, biosimilars, and personalized medicine, the global Protein Characterization and Identification Market is entering a decade of high-velocity growth. According to a new comprehensive analysis by Fact.MR, the market is valued at US$ 18.5 billion in 2025 and is projected to soar to US$ 46.3 billion by 2036, expanding at a robust CAGR of 8.7%.
Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=11169
As…
Global Matcha Market to Hit $11.9B by 2036, Driven by Café Culture - Nestlé, …
The global matcha market is projected to grow from USD 5.1 billion in 2025 to USD 11.9 billion by 2036, expanding at a CAGR of 8.0%, driven by health-conscious consumption, café culture expansion, and increasing use in food, beverages, and nutraceuticals.Rising health awareness, premium tea adoption, and industrial applications are driving strong global growth in the matcha market.
Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=B&rep_id=12134
Quick Stats: Matcha…
More Releases for CAGR
[CAGR of 6.7%] Nanocoatings Market Size, Industry Share, CAGR, Regional Forecast …
The global Nanocoatings Market generated $10.7 billion in 2020, and is projected to reach $20.1 billion by 2030, growing at a CAGR of 6.7% from 2021 to 2030. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and wavering market trends.
Download sample PDF @ https://www.alliedmarketresearch.com/request-sample/2064
According to the report published by Allied Market Research,…
[CAGR of 5.3%] Pigments Market Size, Industry Share, CAGR, Regional Forecast, 20 …
A recent report by Allied Market Research provides a detailed analysis of the pigments market, highlighting its robust growth. The industry was valued at $27.2 billion in 2022 and is projected to surge to $45.4 billion by 2032, exhibiting an impressive CAGR of 5.3% from 2023 to 2032.
This research report identifies the growth drivers behind the market's expansion and delves into the market dynamics using advanced analytical frameworks…
Enzymes Market Expansion CAGR of 4.9% CAGR Anticipated 2025-2034
The Enzymes Market report is an in-depth examination of the global Enzymes Market's general consumption structure, development trends, sales techniques, and top nations' sales. The research looks at well-known providers in the global Enzymes Market industry, as well as market segmentation, competition, and the macroeconomic climate. A complete Enzymes Market analysis takes into account a number of aspects, including a country's population and business cycles, as well as market-specific microeconomic…
Waterproofing Membranes Market is Projected Grow at CAGR of 8% CAGR by 2033
The waterproofing membranes market is anticipated to witness a Compound Annual Growth Rate (CAGR) of 8.0% over the forecast period. By 2023, the estimated market value for waterproofing membranes is substantial, reaching US$ 31.5 billion.
These waterproofing materials comprise thin, impermeable membranes designed to collaborate with asphalt, providing a protective shield for the structural integrity of buildings. The asphalt component in these membranes acts as a safeguard, preserving the underlying membrane…
Electric Bed Market CAGR, Size, Share Grow USD 2,063 Million by 2030 CAGR 13.70%
Global electric bed market size is expected to be worth roughly USD 2,063 million by 2030, growing at a CAGR of more than 13.7% during the projected timeframe of 2022-2030, according to Ameco Research
A significant portion of the population over the age of 60, who often have reduced immunity levels and are more susceptible to neurological disorders, cardiac issues, tumors, and spinal cord compression, is anticipated to have a substantial…
Pediatric Radiology Market Size will Grow at CAGR 7.7% CAGR during 2017-2026
Pediatric Radiology Market:Overview
The pediatric radiology market is likely to register robust growth in the near future. Chronic illnesses among children including neurological disorders such as ADHD are on the rise. According to the US labor bureau, the demand for pediatrician is expected to grow by 24% on average by 2020. This is the highest average growth among all professionals in the United States.
Despite challenges such as training for new…
